The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The Minimally Invasive Thoracic Surgery Market From 2026 To 2030?
The minimally invasive thoracic surgery market has shown strong growth in recent years. It is anticipated to increase from $4.38 billion in 2025 to $4.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. Historically, this growth has been fueled by factors such as the rising incidence of thoracic disorders, the expansion of specialized surgical centers, advancements in minimally invasive surgical instruments, increased surgeon training in thoracoscopic techniques, and a growing patient preference for minimally invasive procedures.
The minimally invasive thoracic surgery market is projected to experience robust expansion in the coming years. This market is set to reach $6.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This anticipated growth is driven by factors such as the increasing embrace of advanced robotic platforms, the growing incorporation of AI-powered surgical planning, the expansion of outpatient thoracic surgery initiatives, the rising need for high-definition imaging technology, and a heightened emphasis on surgical care focused on patient outcomes. Key developments anticipated during this period involve a surge in robotic-assisted thoracic procedures, increased utilization of sophisticated visualization systems, a growing preference for video-assisted surgical methods, the broader deployment of precision energy devices, and a stronger focus on minimizing recovery times post-surgery.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27348&type=smp
What Key Factors Are Affecting The Minimally Invasive Thoracic Surgery Market Demand?
An increasing prevalence of lung ailments is anticipated to drive the expansion of the minimally invasive thoracic surgery market in the future. These conditions include medical issues that impair lung function and breathing, such as asthma, COPD, pneumonia, and lung cancer. The rise in lung disease is largely attributable to tobacco smoking because the harmful chemicals in tobacco damage lung cells’ DNA over time, thereby increasing the probability of uncontrolled cell growth and tumor formation. Minimally invasive treatments assist lung disease patients by targeting and removing or destroying tumors through small incisions or imaging-guided probes, which leads to reduced recovery time, minimized damage to healthy lung tissue, a lower risk of complications, and allows patients to resume normal activities sooner. For instance, in June 2025, data from the Centers for Disease Control and Prevention, a US-based government administration, showed that in 2022, the United States recorded 218,893 new cases of lung cancer, and in 2023, lung cancer resulted in the deaths of 131,584 individuals in the country. Therefore, the escalating occurrence of lung diseases is fueling the growth of the minimally invasive thoracic surgery market.
How Is Segmentation Applied In The Minimally Invasive Thoracic Surgery Market Segment Analysis?
The minimally invasive thoracic surgery market covered in this report is segmented –
1) By Surgical Resection Type: Lobectomy, Wedge Resection, Pneumonectomy, Other Types
2) By Product: Energy Devices, Instruments, Staplers And Disposables, Visualization Systems
3) By Procedure Type: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Thoracic Surgery, Endoscopic Thoracic Surgery, Other Procedure Types
4) By Application: Lung Cancer Surgery, Esophageal Surgery, Mediastinal Surgery, Other Applications
5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Lobectomy: Bilobectomy, Sleeve Lobectomy, Thoracoscopic Lobectomy (VATS Lobectomy), Robotic-Assisted Lobectomy
2) By Wedge Resection: Video-Assisted Thoracoscopic Surgery (VATS) Wedge Resection, Robotic-Assisted Wedge Resection, Open Wedge Resection
3) By Pneumonectomy: Standard Pneumonectomy, Extended Pneumonectomy, Sleeve Pneumonectomy, Thoracoscopic
4) By Other Types: Segmentectomy, Sleeve Resection, Decortication, Bullectomy, Thoracoscopic Resection For Metastasectomy
What Trends Are Influencing Changes In The Minimally Invasive Thoracic Surgery Market?
Major companies within the minimally invasive thoracic surgery market are emphasizing the creation of advanced technologies, like the robotic-assisted surgery platform, to boost surgical accuracy and enhance overall clinical results. A robotic-assisted surgery platform is a system where surgeons manipulate robotic arms to perform minimally invasive procedures with high precision, offering improved accuracy, dexterity, and visualization compared to traditional methods. For example, in June 2024, Monmouth Medical Centre (MMC), a US-based medical institution, launched the Ion Robotic platform, the Aliya PEF system, and intraoperative AI-driven CT imaging. These provide benefits such as superior surgical precision, better patient outcomes, and real-time imaging to support enhanced decision-making. Together, these technologies facilitate minimally invasive, accurate lung cancer diagnosis and treatment, resulting in faster recovery and better outcomes. They also offer real-time navigation, non-thermal tumor ablation, and reduced radiation exposure, encouraging early detection and effective treatment.
Who Are The Companies Participating In The Minimally Invasive Thoracic Surgery Market Environment?
Major companies operating in the minimally invasive thoracic surgery market are Johnson And Johnson Services Inc., Medtronic Plc, Koninklijke Philips N.V., Stryker Corporation, GE Healthcare Inc., Olympus Corporation, Intuitive Surgical Operations Inc., Smith & Nephew plc, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Group Incorporated, CONMED Corporation, Applied Medical Resources Corporation, KLS Martin Group, Aesculap Inc., Medela Inc., Richard Wolf GmbH, B. Braun Melsungen AG, Ackermann Instrumente GmbH, Cmr Surgical, Genesee Biomedical Inc.
Get The Full Minimally Invasive Thoracic Surgery Market Report:
Which Region Is The Top Contributor To The Minimally Invasive Thoracic Surgery Market By Share?
North America was the largest region in the minimally invasive thoracic surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive thoracic surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Minimally Invasive Thoracic Surgery Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Minimally Invasive Thoracic Surgery Market 2026, By The Business Research Company
Rare Disease Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report
Rare Diseases Treatment Market Report
https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report
Rare Neurological Disease Treatment Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model